Paper30144583
Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.
Yegya-Raman N and 8 others. Pract Radiat Oncol, 2019. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy. Papers, record 30144583. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30144583
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Chemoradiotherapy | Major topic |
| Esophagitis | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Radiation Pneumonitis | Major topic |
| Radiotherapy Planning, Computer-Assisted | Major topic |
| Adenocarcinoma | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cone-Beam Computed Tomography | |
| Female | |
| Follow-Up Studies | |
| Four-Dimensional Computed Tomography | |
| Humans | |
| Image Processing, Computer-Assisted | |
| Lung Neoplasms | |
| Male | |
| Margins of Excision | |
| Middle Aged | |
| Positron-Emission Tomography | |
| Prognosis | |
| Radiotherapy Dosage | |
| Radiotherapy, Intensity-Modulated | |
| Retrospective Studies |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA072720 | NCI NIH HHS | United States | P30CA072720 | PubMed and NIH |
Source NIH RePORTER
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11072158 | Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. | Int J Radiat Oncol Biol Phys | 2000 | https://conductscience.org/library/papers/11072158 | PubMed |
| 2 | 17570609 | Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. | Int J Radiat Oncol Biol Phys | 2007 | https://conductscience.org/library/papers/17570609 | PubMed |
| 3 | 24035329 | Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis. | Int J Radiat Oncol Biol Phys | 2013 | https://conductscience.org/library/papers/24035329 | PubMed |
| 4 | 26929893 | Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)? | Cureus | 2016 | https://conductscience.org/library/papers/26929893 | PubMed |
| 5 | 20356642 | Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes. | Radiother Oncol | 2010 | https://conductscience.org/library/papers/20356642 | PubMed |
| 6 | 22425920 | Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma. | J Thorac Oncol | 2012 | https://conductscience.org/library/papers/22425920 | PubMed |
| 7 | 29174428 | Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy. | Int J Radiat Oncol Biol Phys | 2018 | https://conductscience.org/library/papers/29174428 | PubMed |
| 8 | 20643515 | Effect of image-guidance frequency on geometric accuracy and setup margins in radiotherapy for locally advanced lung cancer. | Int J Radiat Oncol Biol Phys | 2011 | https://conductscience.org/library/papers/20643515 | PubMed |
| 9 | 25154893 | Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer. | Radiat Oncol | 2014 | https://conductscience.org/library/papers/25154893 | PubMed |
| 10 | 21440998 | Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer. | Int J Radiat Oncol Biol Phys | 2012 | https://conductscience.org/library/papers/21440998 | PubMed |
| 11 | 27646942 | Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/27646942 | PubMed |
| 12 | 18303441 | Image-guided radiation therapy for non-small cell lung cancer. | J Thorac Oncol | 2008 | https://conductscience.org/library/papers/18303441 | PubMed |
| 13 | 25601342 | Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25601342 | PubMed |
| 14 | 15850904 | Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? | Int J Radiat Oncol Biol Phys | 2005 | https://conductscience.org/library/papers/15850904 | PubMed |
| 15 | 29203290 | Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial. | Radiother Oncol | 2018 | https://conductscience.org/library/papers/29203290 | PubMed |
| 16 | 18029110 | Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. | Int J Radiat Oncol Biol Phys | 2008 | https://conductscience.org/library/papers/18029110 | PubMed |
| 17 | 26623072 | Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy. | Mol Clin Oncol | 2015 | https://conductscience.org/library/papers/26623072 | PubMed |
| 18 | 29933876 | Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology. | Semin Radiat Oncol | 2018 | https://conductscience.org/library/papers/29933876 | PubMed |
| 19 | 17984185 | Involved-field radiation therapy for inoperable non small-cell lung cancer. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17984185 | PubMed |
| 20 | 20351327 | Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20351327 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38270800 | Treatment of node-positive endometrial cancer: chemotherapy, radiation, immunotherapy, and targeted therapy. | Curr Treat Options Oncol | 2024 | https://conductscience.org/library/papers/38270800 | PubMed |
| 38260217 | Adaptive Lung Radiation Therapy in the Era of Immunotherapy: A Single-Center Retrospective Study. | Adv Radiat Oncol | 2024 | https://conductscience.org/library/papers/38260217 | PubMed |
| 38040540 | Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial. | Clin Lung Cancer | 2024 | https://conductscience.org/library/papers/38040540 | PubMed |
| 37781162 | Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis. | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/37781162 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30144583
GET https://conductscience.org/api/papers/v1/30144583/authors